Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Cipla promoters sell 2.53% stake worth Rs 2,637 cr to fund philanthropy
ICICI Prudential MF, Aditya Birla Sun Life MF among top buyers
Ficci commits to adopt 100,000 patients under TB Mukt Bharat Abhiyaan
The scheme aims to bring together all community stakeholders to accelerate the country's progress towards TB elimination
After Q1 results, Cipla warns of margin pressure over cost increases
Q1 net profit up 10 per cent, ties up for biosimilars in emerging markets
Cipla gets WHO nod to sell drug that prevents TB in HIV patients
Q-TIB is a novel fixed-dose combination in a single tablet
